Acetazolamide: Uses and Dosages in Various Medical Conditions
Acetazolamide is a versatile carbonic anhydrase inhibitor used for multiple medical conditions with specific dosing regimens ranging from 125-1000 mg daily depending on the indication, with effectiveness demonstrated for glaucoma, epilepsy, altitude sickness, edema, and idiopathic intracranial hypertension. 1
Primary Indications and Dosages
Glaucoma
- Dosage: 250 mg to 1 g daily, usually in divided doses for amounts over 250 mg 2
- Used as adjunctive therapy to usual glaucoma treatments
- For secondary glaucoma and preoperative treatment of acute congestive (closed-angle) glaucoma: 250 mg every four hours 2
- Some acute cases may respond better to an initial dose of 500 mg followed by 125-250 mg every four hours 2
- The American Academy of Ophthalmology supports these dosing recommendations 1
Epilepsy
- Dosage: 8-30 mg/kg daily in divided doses 2
- Optimum range: 375-1000 mg daily 2
- When adding to existing anticonvulsants: Start with 250 mg once daily 2
- Most effective for petit mal seizures in children, but also beneficial for grand mal, mixed seizure patterns, and myoclonic jerk patterns 2
- Transition from other medications should be gradual 2
Altitude Sickness
- Dosage: 125-250 mg twice daily, starting 24 hours before ascent 1
- Reduces risk of acute mountain sickness by 48% compared to placebo 3
- Lower dose of 62.5 mg twice daily has been shown to be non-inferior to 125 mg twice daily in prevention 4
- Improves nocturnal oxygenation at high altitudes 1
Congestive Heart Failure
- Dosage: 250-375 mg once daily in the morning (5 mg/kg) 2
- Most effective when given on alternate days or for two days alternating with a day of rest 2
- Does not eliminate need for other therapy such as digitalis, bed rest, and salt restriction 2
Drug-Induced Edema
- Dosage: 250-375 mg once daily for one or two days, alternating with a day of rest 2
Off-Label Uses
Obstructive Sleep Apnea
- The European Respiratory Society suggests use only in the context of clinical trials 5
- Can reduce sleep apnea intensity by up to 45% 5
- Improves nocturnal oxygenation, especially at high altitudes 5
- Not approved for OSA treatment 5
Idiopathic Intracranial Hypertension
- Reduces cerebrospinal fluid production and intracranial pressure 6
- Can help avoid invasive procedures in patients with CSF leaks or elevated ICP 6
Other Uses
- Ventilator weaning for COPD patients 6
- Prevention of high-dose methotrexate toxicity 6
- Prevention of contrast-induced nephropathy 6
Contraindications and Precautions
Contraindicated in:
Dosage adjustment:
- For creatinine clearance <50 mL/min, do not administer more frequently than every 12 hours 6
Adverse Effects
Common side effects:
Serious side effects:
Monitoring Recommendations
- Monitor serum electrolytes, particularly for hypokalemia 1
- Monitor renal function 1
- Monitor acid-base status 1
- Watch for signs of dehydration, especially when combined with other diuretics 1
- Avoid combining with other diuretics due to increased risk of dehydration and electrolyte imbalances 1
Clinical Pearls
- Acetazolamide's pharmacologic effects last longer than its 4-8 hour plasma half-life 6
- For altitude sickness, proper acclimatization remains essential (gradual ascent of 300-600m/day above 2500m) 1
- Immediate descent is the primary treatment for severe altitude illness, regardless of medication use 1
- Side effects appear to be dose-related, suggesting that using the lowest effective dose may improve tolerability 4
- When used for epilepsy, partial tolerance may develop to the antiepileptic activity 7